Strong start to FY26 with ₹875 Cr revenue; USFDA clearance, 20+ audits, and peptide lab expansion underline quality-first strategy Bengaluru, 23 July 2025 ,  Syngene International Ltd. began FY26 with solid performance in the first quarter, reporting an 11% year-on-year increase in revenue from operations to ₹875 crore and a 59% surge in profit after … Continue reading Syngene Q1FY26: Revenue up 11%, PAT surges 59% as biologics and peptides scale